ALLO - Allogene Therapeutics, Inc.
2.26
-0.150 -6.637%
Share volume: 6,330,340
Last Updated: 03-27-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$2.41
-0.15
-0.06%
Summary score
37%
Profitability
35%
Dept financing
24%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-11.2%
Return on sales
-247045.62%
Return on invested capital
0%
Total debt ratio
20.97%
Debt ratio change over timeo
-1.79%
Current Ratio
10.35%
Quick Ratio
0%
Cash Position Ratio
1.98%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-11.32%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
27.22%
Debt ratio change over timeo
0%
Current Ratio
8.69%
Quick Ratio
0%
Cash Position Ratio
1.46%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-10.14%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
29.66%
Debt ratio change over time
0%
Current Ratio
7.93%
Quick Ratio
0%
Cash Position Ratio
1.59%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-42.6%
Return on sales
909190.12%
Return on invested capital
0%
Total debt ratio
-178.64%
Debt ratio change over time
-1.79%
Current Ratio
-89.33%
Quick Ratio
0%
Cash Position Ratio
-16.89%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALLO | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 5.97% | 8.91% |
| Return on assets | -11.2% | 2.97% | 3.34% | 2.04% |
| Return on sales | -247045.62% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | 0% | 0% | 3.51% | 10.25% |
| Profitability | 0% | 47% | 75% | 85% |
| Total debt ratio | 20.97% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -1.79% | 14.34% | 187.33% | 9.75% |
| Dept financing | 6% | 27% | 43% | 13% |
| Current Ratio | 8.69% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.46% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 33% | 27% | 39% |
| Short-term ratios | ALLO | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -11.32% | 3.27% | 4.7% | 1.36% |
| Return on sales | 0% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 27.22% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 25% | 18% | 10% |
| Current Ratio | 8.69% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.46% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 24% | 32% | 46% |